Also, in vivo, in ApoE−/− mice, it has been shown that using 25 mg/kg/day of CRC can decrease LDL-C, TC, and TG while increasing HDL-C levels, resulting in a significantly decreased formation of atherosclerotic plaque [94]. Here, APOE is linked to colorectal carcinoma.